Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS® Oxybutynin vs Ditropan® in Urge or Mixed Urinary Incontinence
NCT00269750Phase 3Completed
- Sponsor
- ALZA Corporation
- Start
- Jul 1996
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of oxybutynin in urge urinary incontinence (UUI), mixed urinary incontinence (MUI), sponsored by ALZA Corporation. Started Jul 1996; status: completed.
02
Drugs
oxybutynin
03
Conditions
urge urinary incontinence (UUI)mixed urinary incontinence (MUI)
Beyond the preview
Go deeper on NCT00269750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269750.